RAPT Competitors & Alternatives
Compare RAPT Therapeutics Inc with similar stocks in the same industry
Biotechnology
RAPT
Main Stock$58.02
+0.07%
Tradestie Score
50
Market Cap
$450.49M
Revenue Growth
-100.0%
Analyst Upside
0.0%
Supply-Chain & Ecosystem Map (Customers, Suppliers & Direct Competitors)
Bottleneck Score: 2/10
Drug Discovery Biotech
Small Molecule Drug Discovery
Top Competitors
216 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ABCL
AbCellera Biologics Inc. Common Shares
|
$11.14
-3.08%
|
$1.78B | - | 62 | Compare |
|
DYN
Dyne Therapeutics, Inc. Common Stock
|
$16.70
-2.71%
|
$1.78B | - | 51 | Compare |
|
TWST
Twist Bioscience Corporation Common Stock
|
$105.61
-5.37%
|
$1.77B | - | 52 | Compare |
|
VRDN
Viridian Therapeutics, Inc. Common Stock
|
$30.37
-1.64%
|
$1.74B | - | 37 | Compare |
|
CLDX
Celldex Therapeutics, Inc
|
$28.72
-0.40%
|
$1.68B | - | 55 | Compare |
|
MNKD
Mannkind Corporation
|
$3.95
-4.48%
|
$1.65B | - | 36 | Compare |
|
EWTX
Edgewise Therapeutics, Inc. Common Stock
|
$44.16
-3.85%
|
$1.63B | 5.5 | 34 | Compare |
|
BHVN
Biohaven Ltd.
|
$13.95
+0.90%
|
$1.57B | - | 42 | Compare |
|
VCEL
Vericel Corporation
|
$57.68
+1.26%
|
$1.56B | 90.3 | 35 | Compare |
|
DNTH
Dianthus Therapeutics, Inc. Common Stock
|
$88.76
-3.33%
|
$1.55B | - | 32 | Compare |
More RAPT Analysis
Data updated: Nov 16, 2026 | Industry: Biotechnology (SIC 2834)
216 stocks in this industry